CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-17 | Encrantz Staffan Director | Purchase | +250,000 | $8.49 | $2.1M | 551,802 |
| 2022-05-16 | Encrantz Staffan Director | Purchase | +300,000 | $8.20 | $2.5M | 301,802 |
| 2022-05-13 | Encrantz Staffan Director | Purchase | +1,802 | $7.98 | $14K | 1,802 |
| 2022-05-13 | Selnick Jesse Chief Financial Officer | Purchase | +5,000 | $8.28 | $41K | 249,225 |
| 2022-05-11 | Selnick Jesse Chief Financial Officer | Option exercise | +120,000 | $0.35 | $42K | 369,225 |
| 2022-05-11 | Selnick Jesse Chief Financial Officer | Option exercise | +30,000 | $0.62 | $19K | 399,225 |
| 2022-05-11 | Selnick Jesse Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −120,000 | 0 | ||
| 2022-05-11 | Selnick Jesse Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −30,000 | 10,000 | ||
| 2022-03-25 | Park Sam Boong Chief Operating Officer | Option exercise | +3,666 | $1.96 | $7K | 44,664 |
| 2022-03-15 | Larsen-Becker Brenda Jane Director | Grant or award · Restricted Stock Units | +17,923 | 17,923 | ||
| 2022-02-26 | Park Sam Boong Chief Operating Officer | Option exercise | +16,666 | $1.96 | $33K | 40,998 |
| 2022-02-09 | Badawi Paul President and CEO | Grant or award · Restricted Stock Units | +87,800 | 87,800 | ||
| 2022-02-09 | Badawi Paul President and CEO | Grant or award · Stock Option (Right to Buy) | +351,300 | 351,300 | ||
| 2022-02-09 | HAYDEN JEREMY B. Chief Legal Officer | Grant or award · Restricted Stock Units | +12,000 | 12,000 | ||
| 2022-02-09 | HAYDEN JEREMY B. Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +48,200 | 48,200 | ||
| 2022-02-09 | Selnick Jesse Chief Financial Officer | Grant or award · Restricted Stock Units | +28,100 | 28,100 | ||
| 2022-02-09 | Selnick Jesse Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +112,400 | 112,400 | ||
| 2022-02-09 | Badawi David Chief Technology Officer | Grant or award · Restricted Stock Units | +28,100 | 28,100 | ||
| 2022-02-09 | Badawi David Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +112,400 | 112,400 | ||
| 2022-02-09 | O'Neil Shawn Chief Commercial Officer | Grant or award · Restricted Stock Units | +18,100 | 18,100 |
Page 13 of 16 · 302 trades